We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Tracee Ellis Ross, Dan Levy, Adam Curtis, Dan Pearson, Lisa Brice, Florian Krewer, Simone Ashley and others join a special edition dedicated to the future and finding the positives in life
Craft farming, terroir, tasting notes and appellations is the new language of getting high
Just three prescriptions have been administered by the NHS since 2018, industry reports
Hopes for further liberalisation in the US and beyond spur flurry of dealmaking
State becomes the 16th in the US to allow marijuana sales after lawmakers broker agreement
Case for legalising marijuana is not as straightforward as its advocates say
Maker of Lucky Strike cigarettes moves beyond nicotine in effort to attract consumers
World’s largest marijuana retailer says relaxed attitudes are ‘taking hold’ across continent
Analysis shows 43 out of 59 companies in major marijuana funds were lossmaking
Assets under management by pot-tracking ETFs are at an all-time high.
US group snaps up UK maker of marijuana-based epilepsy drug as sector interest grows
Groups eye IPOs after financial regulator sets out rules for sector
Start-up secures first permit in more than 20 years for commercial cannabis cultivation
Lack of investment-grade companies and questions over legality run counter to optimism
The happy, hazy days of 2018 look a long way away
How to deal with social injustice via the magic of the capital markets, and Jay-Z.
Biotech bosses hail breakthrough as magic mushroom ingredient decriminalised in parts of US
Prime minister and a former leader backed the campaign to legalise pot
Further liberalisation would lift many constraints, including the ability of institutions to invest
Chrystal Capital hopes to profit from legalisation moves even though shares in sector have struggled
FCA guidance clears way for companies providing products for medical use to float on stock exchange
Gold stands out in a dazzling year for the industry. Plus: finance experts look at how best to invest for Brexit; actively managed ETFs tested as investors switch focus; what is driving rapid growth in Asia and will it last?
Companies warn current regulations will encourage investment to shift elsewhere in Europe
Silverpeak subsidiary aims to become world’s largest producer of medicinal marijuana by 2025
Magazine group buys outlets from one of America’s largest retail and wholesale marijuana distributors
International Edition
